Anticancer Effect and Molecular Targets of Saffron Carotenoids

S Zahra Bathaie1, Azam Bolhassani2, Fuyuhiko Tamanoi3

  • 1Department of Clinical Biochemistry, Tarbiat Modares University, Tehran, Iran; Department of Microbiology, Immunology and Molecular Genetics, Jonsson Comprehensive Cancer Center, Molecular Biology Institute, University of California, Los Angeles, California, USA.

The Enzymes
|April 23, 2016
PubMed

Insights

Saffron carotenoids, crocin and crocetin, demonstrate anticancer effects through various molecular mechanisms. These compounds show promise for cancer therapy and other diseases due to their safety and antioxidant properties.

Area of Science:

  • Pharmacology and Molecular Biology
  • Natural Product Chemistry

Background:

  • Saffron carotenoids, crocin and crocetin, possess known anticancer activities.
  • Their mechanisms involve radical scavenging and antioxidant defense activation.
  • Emerging evidence suggests additional molecular pathways are involved.

Purpose of the Study:

  • To explore the diverse molecular mechanisms of action for crocin and crocetin.
  • To investigate the distinct anticancer effects of crocin and crocetin despite structural similarities.
  • To highlight the role of ROS-dependent signaling pathways in crocetin's anticancer activity.

Main Methods:

  • Review of recent studies on saffron carotenoids' molecular mechanisms.
  • Analysis of in vitro and in vivo cancer models.
  • Examination of cellular signaling pathways, including ROS-dependent pathways.

Main Results:

  • Crocin and crocetin exhibit anticancer activity via multiple molecular mechanisms.
  • Distinct pathways are implicated in the anticancer effects of crocin and crocetin.
  • Crocetin's anticancer effects are particularly linked to ROS-dependent signaling.

Conclusions:

  • Saffron compounds crocin and crocetin offer a safe and potentially inexpensive cancer therapy.
  • These compounds may also serve as therapeutic agents for diabetes, Alzheimer's, and cardiovascular diseases.
  • Further research into their molecular mechanisms can optimize therapeutic applications.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.7K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.7K
Cancer Prevention02:59

Cancer Prevention

3.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K